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Background: TandemHeart® Percutaneous Ventricular Assist Device (pVAD) can be used for hemodynamic support of patients with cardiogenic 
shock (CS) until cardiac recovery occurs or as a bridge to a surgical VAD or cardiac transplant.
Methods: Consecutive patients who underwent TandemHeart® pVAD placement for CS were prospectively followed for improvement in 
hemodynamic variables. Right heart catheter measurements were recorded and values before and 24-hours after pVAD insertion were compared. The 
primary endpoint was myocardial recovery, survival to surgical VAD or transplant.
Results: Among the 37 patients included in this study, 16 (43%) had myocardial recovery, 6 (16%) proceeded to a surgical VAD and 1 patient was 
transplanted. Hemodynamic variables at baseline and 24-hours following pVAD insertion are reported in Table1. Compared to baseline, the cardiac 
output and cardiac index increased while mean pulmonary capillary wedge pressure, right atrial pressure, and pulmonary arterial pressure decreased 
at 24-hours. A greater percent change (% Change in Table 1) was observed in patients who had myocardial recovery or survived to surgical VAD or 
transplant when compared to patients who had no myocardial recovery.
Conclusion: In this single-center experience, hemodynamic parameters improved 24-hours following TandemHeart® pVAD insertion in all patients 
but improved to a greater extent in patients who had myocardial recovery compared to those who did not. 
Hemodynamic parameters pre- and 24-hours post- TandemHeart® pVADTM insertion
Myocardial Recovery* (n=23) No Myocardial Recovery (n=14)
Hemodynamic 
Parameters
Baseline 24-hours p-value % Change Baseline 24-hours p-value % Change
RA Mean (mmHg) 18±6 12±4 0.025 -33.3 16±5 13±2 0.034 -18.8
PA Mean (mmHg) 33±8 26±4 0.008 -21.2 30±6 25±4 0.025 -16.7
PCWP (mmHg) 24±8 17±5 0.004 -29.2 20±6 13±2 0.066 -35
CO (L/min) 3.43±1.31 6.07±2.11 0.003 77 3.18±1.66 5.12±1.64 0.058 61
CI (L/min/m2) 1.61±0.72 3.44±1.15 0.018 113.7 1.85±0.76 2.68±0.80 0.285 44.9
SVR (dynes/s•cm-5) 1454±693 1135±535 0.139 -21.9 1374±794 1180±795 0.144 -14.1
PVR (dynes/s•cm-5) 285±192 188±195 0.600 -27.1 231±159 171±53 0.655 -26
RA, right atrial; PA, pulmonary artery; PCWP, pulmonary capillary wedge pressure;
CO, cardiac output; CI, cardiac index; SVR, systemic vascular resistance; PVR, pulmonary vascular resistance.
*Includes those patients who proceeded to surgical VAD and transplant
